Takeda Pharmaceutical Co. Ltd., 10% Owner at Day One Biopharmaceuticals, Inc. (DAWN), sold 536,356 shares at $19.50 ($9.9M) on 2021-12-07, disclosed to the SEC on 2021-12-09.
Open-market sale of $9.9M DAWN by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.43 | 128,745 | $2.4M | 24.1% |
| 2 | $18.43 | 128,745 | $2.4M | 24.1% |
| 3 | $19.50 | 58,190 | $1.1M | 11.5% |
| 4 | $18.03 | 110,338 | $2.0M | 20.2% |
| 5 | $18.03 | 110,338 | $2.0M | 20.2% |
| Total | $18.38 avg | 536,356 |
| $9.9M |
| 100% |
| Filing → |
| PHAT | SELL | 2021-11-08 | $20.9M | — | Filing → |
| PHAT | SELL | 2021-07-09 | $183K | — | Filing → |
| PHAT | SELL | 2021-07-06 | $582K | — | Filing → |